Covidien plc | 2013 | FY | 3

Goodwill and Intangible Assets
The changes in the carrying amount of goodwill for fiscal 2012 and 2013 were as follows:
(Dollars in Millions)
Medical
Devices
 
Pharmaceuticals
 
Medical
Supplies
 
Total
Goodwill at September 30, 2011
$
6,786

 
$
508

 
$
389

 
$
7,683

Acquisitions
872

 
—

 
—

 
872

Currency translation
(13
)
 
—

 
—

 
(13
)
Goodwill at September 28, 2012
7,645

 
508

 
389

 
8,542

Acquisitions
147

 
24

 
—

 
171

Currency translation and other
(9
)
 
—

 
—

 
(9
)
Transfer of goodwill to Mallinckrodt
—

 
(532
)
 
—

 
(532
)
Goodwill at September 27, 2013
$
7,783

 
$
—

 
$
389

 
$
8,172


 
The gross carrying amount and accumulated amortization of intangible assets at the end of fiscal 2013 and 2012 were as follows:
 
2013
 
2012
(Dollars in Millions)
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Gross
Carrying
Amount
 
Accumulated
Amortization
Amortizable:
 
 
 
 
 
 
 
Completed technology
$
2,229

 
$
890

 
$
2,577

 
$
906

Customer relationships
959

 
213

 
960

 
155

Other
161

 
86

 
345

 
149

Total
$
3,349

 
$
1,189

 
$
3,882

 
$
1,210

Non-Amortizable:
 
 
 
 
 
 
 
Trademarks
$
322

 
 
 
$
354

 
 
In-process research and development
205

 
 
 
59

 
 
Total
$
527

 
 
 
$
413

 
 

Gross amortizable intangible assets, accumulated amortization and indefinite-lived intangible assets of $648 million, $271 million and $54 million, respectively, were transferred to Mallinckrodt in connection with the 2013 separation. Intangible asset amortization expense from continuing operations for fiscal 2013, 2012 and 2011 was $222 million, $197 million and $175 million, respectively. Amortization expense associated with the intangible assets included on the Company’s balance sheet as of September 27, 2013 is expected to be as follows:
(Dollars in Millions)
 
Fiscal 2014
$
223

Fiscal 2015
222

Fiscal 2016
216

Fiscal 2017
213

Fiscal 2018
209

us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock